Pulmonary hypertension encompasses a range of conditions directly or indirectly leading to
elevated pressures within the pulmonary arteries. Five main groups of pulmonary …

Major advances in pulmonary arterial hypertension, pulmonary hypertension (PH)
associated with lung disease, and chronic thromboembolic PH cast new light on the …

Background: Historical data suggesting poor survival in patients with aortic stenosis (AS)
who do not undergo treatment are largely confined to patients with severe AS. Objectives …

Background In pulmonary hypertension subgroups, elevated pulmonary vascular resistance
(PVR) of 3· 0 Wood units or more is associated with poor prognosis. However, the spectrum …

Aims To examine the characteristics/prognostic impact of diastolic dysfunction (DD)
according to 2016 American Society of Echocardiography (ASE) and European Society of …

Aims We investigated the sex‐based risk of mortality across the spectrum of left ventricular
ejection fraction (LVEF) in a large cohort of patients in Australia. Methods and results …

Pulmonary hypertension (PH) is an independent risk factor for adverse clinical outcome,
particularly in left heart disease (LHD) patients. Recent advances have clarified the mean …

Background The prevalence and prognostic impact of tricuspid regurgitation (TR) remain
incompletely characterized. Methods The distribution of TR severity was analyzed in …

Importance Current guidelines recommend evaluation for echocardiographically estimated
right ventricular systolic pressure (RVSP) greater than 40 mm Hg; however, this threshold …

Pulmonary arterial hypertension (PAH) is rare and, if untreated, has a median survival of 2–3
years. Pulmonary arterial hypertension may be idiopathic (IPAH) but is frequently associated …